Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Viremia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07747987
What this trial is testing

Improving Management of Recipients of Care With HIV Viremia to Optimize Viral Suppression in Zambia: A Process and Outcome Evaluation

Who this might be right for
HIV - Human Immunodeficiency Virus
Centre for Infectious Disease Research in Zambia 548
Not applicableLooking for participantsNCT06605053
What this trial is testing

Optimizing Prevention and Care for Pregnant and Postpartum Adolescent Girls and Young Women With HIV in Tanzania

Who this might be right for
HIV Antiretroviral Therapy (ART) AdherencePMTCTPregnancy+3 more
Karolinska Institutet 222
Post-approval studies (Phase 4)Study completedNCT00966329
What this trial is testing

Switching the Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) or Protease Inhibitor (PI) to Maraviroc in HIV Subjects

Who this might be right for
HIVHIV Infections
Germans Trias i Pujol Hospital 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07379203
What this trial is testing

ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse

Who this might be right for
Cytomegalovirus (CMV) Infection
Wits Health Consortium (Pty) Ltd 130
Not applicableUnknownNCT02411071
What this trial is testing

Clinical Implications of HIV Low-level Viremia at Times of Highly Active Antiretroviral Treatment Regimens

Who this might be right for
HIV-infection
University Hospital, Essen 1,000
Large-scale testing (Phase 3)WithdrawnNCT01605084
What this trial is testing

Second-line Treatment of HIV-1 With Ritonavir Boosted Atazanavir or Darunavir With an Optimized NRTI Backbone

Who this might be right for
HIV
Bristol-Myers Squibb
Not applicableStudy completedNCT00867854
What this trial is testing

Treatment De-Intensification and Residual HIV-1 in Youth

Who this might be right for
HIV-1HIV Infections
University of North Carolina, Chapel Hill 34
Not applicableEnrolling By InvitationNCT06604663
What this trial is testing

Data Science and Qualitative Research for Decision Support in the HIV Care Cascade

Who this might be right for
Human Immunodeficiency VirusTreatment AdherenceTreatment Compliance+4 more
Brown University 80,000
Testing effectiveness (Phase 2)Study completedNCT01933594
What this trial is testing

Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 59
Not applicableNo Longer AvailableNCT02822495
What this trial is testing

Expanded Access Protocol for Tabelecleucel for Patients With Epstein-Barr Virus-Associated Viremia or Malignancies

Who this might be right for
Epstein-Barr Virus (EBV) InfectionsLymphoproliferative DisordersEBV+ Associated Lymphoma+9 more
Atara Biotherapeutics
Testing effectiveness (Phase 2)Looking for participantsNCT04513626
What this trial is testing

HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label

Who this might be right for
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida 150
Large-scale testing (Phase 3)Study completedNCT00006145
What this trial is testing

Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV

Who this might be right for
Cytomegalovirus InfectionsHIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 350
Not applicableStudy completedNCT00050063
What this trial is testing

Effects of Therapeutic HIV Vaccination on Control of HIV After Discontinuation of Anti-HIV Drugs

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 78
Early research (Phase 1)WithdrawnNCT01909414
What this trial is testing

Evaluating the Safety and Immune Response of DNA/MVA Vaccines in HIV-1-Infected Young Adults Taking Anti-HIV Medications

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)Study completedNCT00515827
What this trial is testing

Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 53
Post-approval studies (Phase 4)Ended earlyNCT00855413
What this trial is testing

HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine

Who this might be right for
Acute HIV InfectionHIV Infections
University of North Carolina, Chapel Hill 15
Early research (Phase 1)Study completedNCT02652546
What this trial is testing

CC-11050 in Human Immunodeficiency Virus-1-Infected Adults With Suppressed Plasma Viremia on Antiretroviral Therapy (APHRODITE)

Who this might be right for
HIV, Inflammation
National Institute of Allergy and Infectious Diseases (NIAID) 38
Large-scale testing (Phase 3)Study completedNCT00025909
What this trial is testing

Intermittent vs. Continuous HAART to Treat Chronic HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 90
Testing effectiveness (Phase 2)Study completedNCT00000848
What this trial is testing

The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 144
Large-scale testing (Phase 3)Study completedNCT00160329
What this trial is testing

Atazanavir or Boosted Atazanavir Substitution for Ritonavir Boosted PI in Patients With Hyperlipidemia

Who this might be right for
HyperlipidemiaHIV Infections
Stanford University 60
Next Page